Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

18.05
Delayed Data
As of Jun 23
 +0.85 / +4.94%
Today’s Change
9.05
Today|||52-Week Range
24.00
+21.14%
Year-to-Date

Today’s Trading

Previous close17.20
Today’s open17.10
Day’s range16.85 - 18.10
Volume1,263,839
Average volume (3 months)287,980
Market cap$635.5M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)+5.47%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.16

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.14-0.85%
MGNXMacroGenics Inc-0.08-0.43%
RETAReata Pharmaceutical...-0.29-0.99%
PRTKParatek Pharmaceutic...-0.35-1.45%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts